These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38353623)

  • 21. Engineering guide RNA to reduce the off-target effects of CRISPR.
    Wu J; Yin H
    J Genet Genomics; 2019 Nov; 46(11):523-529. PubMed ID: 31902584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR/Cas9-Mediated Gene Knockout and Knockin Human iPSCs.
    Petazzi P; Menéndez P; Sevilla A
    Methods Mol Biol; 2022; 2454():559-574. PubMed ID: 33190185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Base Editing in Human Cells to Produce Single-Nucleotide-Variant Clonal Cell Lines.
    Vasquez CA; Cowan QT; Komor AC
    Curr Protoc Mol Biol; 2020 Dec; 133(1):e129. PubMed ID: 33151638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of two ISL1-tdTomato reporter human induced pluripotent stem cell lines using CRISPR-Cas9 genome editing.
    Tsukamoto S; Nakade K; Wakabayashi T; Nakashima K; Takami M; Hemmi Y; Kuramochi Y; Shimizu T; Arai Y; Matsuo-Takasaki M; Noguchi M; Nakamura Y; Miwa Y; Hayashi Y
    Stem Cell Res; 2021 May; 53():102363. PubMed ID: 34087992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
    Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
    Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved prime editing allows for routine predictable gene editing in Physcomitrium patens.
    Perroud PF; Guyon-Debast A; Casacuberta JM; Paul W; Pichon JP; Comeau D; Nogué F
    J Exp Bot; 2023 Oct; 74(19):6176-6187. PubMed ID: 37243510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid Generation of Human Genetic Loss-of-Function iPSC Lines by Simultaneous Reprogramming and Gene Editing.
    Tidball AM; Dang LT; Glenn TW; Kilbane EG; Klarr DJ; Margolis JL; Uhler MD; Parent JM
    Stem Cell Reports; 2017 Sep; 9(3):725-731. PubMed ID: 28781079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient Generation and Correction of Mutations in Human iPS Cells Utilizing mRNAs of CRISPR Base Editors and Prime Editors.
    Sürün D; Schneider A; Mircetic J; Neumann K; Lansing F; Paszkowski-Rogacz M; Hänchen V; Lee-Kirsch MA; Buchholz F
    Genes (Basel); 2020 May; 11(5):. PubMed ID: 32384610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR tools.
    Celotti M; Derks LLM; van Es J; van Boxtel R; Clevers H; Geurts MH
    STAR Protoc; 2024 Sep; 5(3):103189. PubMed ID: 39003744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deciphering pathogenicity of variants of uncertain significance with CRISPR-edited iPSCs.
    Guo H; Liu L; Nishiga M; Cong L; Wu JC
    Trends Genet; 2021 Dec; 37(12):1109-1123. PubMed ID: 34509299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR/Cas9 gene editing of a SOX9 reporter human iPSC line to produce two TRPV4 patient heterozygous missense mutant iPSC lines, MCRIi001-A-3 (TRPV4 p.F273L) and MCRIi001-A-4 (TRPV4 p.P799L).
    Nur Patria Y; Stenta T; Lilianty J; Rowley L; Stanley EG; Elefanty AG; Bateman JF; Lamandé SR
    Stem Cell Res; 2020 Oct; 48():101942. PubMed ID: 32771907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient introduction of an isogenic homozygous mutation to induced pluripotent stem cells from a hereditary hearing loss family using CRISPR/Cas9 and single-stranded donor oligonucleotides.
    Dong Y; Peng T; Wu W; Tan D; Liu X; Xie D
    J Int Med Res; 2019 Apr; 47(4):1717-1730. PubMed ID: 30819013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted mutagenesis in human iPSCs using CRISPR genome-editing tools.
    Long Y; Cech TR
    Methods; 2021 Jul; 191():44-58. PubMed ID: 33444739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells.
    Hendel A; Bak RO; Clark JT; Kennedy AB; Ryan DE; Roy S; Steinfeld I; Lunstad BD; Kaiser RJ; Wilkens AB; Bacchetta R; Tsalenko A; Dellinger D; Bruhn L; Porteus MH
    Nat Biotechnol; 2015 Sep; 33(9):985-989. PubMed ID: 26121415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
    Vermersch E; Jouve C; Hulot JS
    Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR/Cas9-Directed Genome Editing of Cultured Cells.
    Yang L; Yang JL; Byrne S; Pan J; Church GM
    Curr Protoc Mol Biol; 2014 Jul; 107():31.1.1-31.1.17. PubMed ID: 24984853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of a gene corrected human isogenic IBMS-iPSC-014-C from polycystic-kidney-disease induced pluripotent stem cell line using CRISPR/Cas9.
    Liu CL; Huang CY; Chen HC; Lu HE; Hsieh PCH; Lee JJ
    Stem Cell Res; 2020 May; 45():101784. PubMed ID: 32361310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient and allele-specific genome editing of disease loci in human iPSCs.
    Smith C; Abalde-Atristain L; He C; Brodsky BR; Braunstein EM; Chaudhari P; Jang YY; Cheng L; Ye Z
    Mol Ther; 2015 Mar; 23(3):570-7. PubMed ID: 25418680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair.
    Ababneh NA; Scaber J; Flynn R; Douglas A; Barbagallo P; Candalija A; Turner MR; Sims D; Dafinca R; Cowley SA; Talbot K
    Hum Mol Genet; 2020 Aug; 29(13):2200-2217. PubMed ID: 32504093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.